Clinical Trial Update: The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B [NA]

View source ↗

Summary

A completed clinical trial update for the PARTNER II trial on transcatheter aortic valve replacement (TAVR) devices, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Calcific Aortic Stenosis

Drugs mentioned

• Edwards Lifesciences transcatheter aortic valve

Snippet

Sponsor: Edwards Lifesciences | Conditions: Severe, Symptomatic | NA | Status: COMPLETED | Results posted: 2018-08-14